Yan et al. compared a photosensitizer pyropheophorbide-a (Pyro), which does not have tumor selectivity, with a novel photosensitizer, CD133–Pyro, obtained via the conjugation of Pyro to a peptide targeting CD133 [171]. The gene discussed is PROM1; the disease is neoplasm.